| Dr Janet A Schmidt, PHD | |
|
233 Club Dr, San Carlos, CA 94070-1616 | |
| (301) 806-5596 | |
| Not Available |
| Full Name | Dr Janet A Schmidt |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 233 Club Dr, San Carlos, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962958918 | NPI | - | NPPES |
| 968396437 | Other | CA | DUNS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 24977 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janet A Schmidt, PHD 233 Club Dr, San Carlos, CA 94070-1616 Ph: (301) 806-5596 | Dr Janet A Schmidt, PHD 233 Club Dr, San Carlos, CA 94070-1616 Ph: (301) 806-5596 |
News Archive
Senior citizens and combat soldiers don't usually have much in common-unless the topic is bone injuries. Among both groups, mending serious skeletal injuries-whether caused by a blast or a common fall-is a costly, complicated challenge.
Sydney University researchers have identified how crocodiles and other reptiles detect temperature - shedding new light on their adaptation to environmental changes and pointing to new pain treatments for humans.
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.
Researchers in the Center for Translational Medicine at the University of Montana have been awarded $2.5 million in funding from the National Institutes of Health to identify and advance a COVID-19 vaccine candidate.
› Verified 5 days ago
Dr. Renee Maria Aguilar, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 957 Industrial Rd, San Carlos, CA 94070 Phone: 650-832-6900 | |
Dr. Alexandra Pauline Diddams, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1303 San Carlos Ave, San Carlos, CA 94070 Phone: 650-439-0620 | |
Dr. Christine D'alessandro, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 957 Industrial Rd, San Carlos, CA 94070 Phone: 415-375-7632 | |
Dr. Ubaldo F Sanchez, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 727 Industrial Rd, Suite 102, San Carlos, CA 94070 Phone: 650-571-5986 Fax: 650-458-8250 | |
Taryn Weinkam, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1335 San Carlos Ave Ste B, San Carlos, CA 94070 Phone: 650-822-7554 | |
Gennifer Amanda Alie, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 610 Elm St Ste 212, San Carlos, CA 94070 Phone: 650-591-9623 | |
Christy Aleene Blevins, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 520 Elm St, Apt 32, San Carlos, CA 94070 Phone: 512-925-5486 |